STATE STREET CORP - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 36 filers reported holding REPROS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$9,000
+125.0%
13,5510.0%0.00%
Q3 2017$4,000
-33.3%
13,5510.0%0.00%
Q2 2017$6,000
-62.5%
13,5510.0%0.00%
Q1 2017$16,000
-15.8%
13,5510.0%0.00%
Q4 2016$19,000
-34.5%
13,551
-2.2%
0.00%
Q3 2016$29,000
+38.1%
13,8510.0%0.00%
Q2 2016$21,000
+61.5%
13,8510.0%0.00%
Q1 2016$13,000
-18.8%
13,8510.0%0.00%
Q4 2015$16,000
-84.5%
13,8510.0%0.00%
Q3 2015$103,000
-36.0%
13,851
-38.6%
0.00%
Q2 2015$161,000
-94.8%
22,551
-93.8%
0.00%
Q1 2015$3,110,000
-13.3%
362,040
+0.7%
0.00%
Q4 2014$3,588,000
-66.8%
359,459
-67.1%
0.00%
-100.0%
Q3 2014$10,818,000
-32.1%
1,092,615
+18.6%
0.00%
-50.0%
Q2 2014$15,937,000
-17.3%
921,128
-15.2%
0.00%0.0%
Q1 2014$19,279,000
-44.7%
1,086,636
-44.0%
0.00%0.0%
Q4 2013$34,854,000
+73.9%
1,940,063
+159.5%
0.00%0.0%
Q3 2013$20,039,000
+282.9%
747,748
+163.6%
0.00%
+100.0%
Q2 2013$5,234,000283,6520.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Allegis Investment Advisors, LLC 342,709$569,0000.29%
GENERAL AMERICAN INVESTORS CO INC 396,123$638,0000.07%
Alambic Investment Management, L.P. 69,191$111,0000.03%
Acrospire Investment Management LLC 15,119$24,0000.02%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 98,486$158,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,030$507,0000.01%
SIMPLEX TRADING, LLC 86,054$138,0000.01%
A.R.T. Advisors, LLC 34,315$55,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$18,0000.00%
Renaissance Technologies 561,713$904,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders